| Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection PK Drain, KL Bajema, D Dowdy, K Dheda, K Naidoo, SG Schumacher, ... Clinical microbiology reviews 31 (4), 10.1128/cmr. 00021-18, 2018 | 537 | 2018 |
| MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage MJ Harriff, C McMurtrey, CA Froyd, H Jin, M Cansler, M Null, A Worley, ... Science immunology 3 (25), eaao2556, 2018 | 123 | 2018 |
| Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens EW Meermeier, BF Laugel, AK Sewell, AJ Corbett, J Rossjohn, ... Nature communications 7 (1), 12506, 2016 | 120 | 2016 |
| MAIT cells and microbial immunity EW Meermeier, MJ Harriff, E Karamooz, DM Lewinsohn Immunology and cell biology 96 (6), 607-617, 2018 | 81 | 2018 |
| TRAV1-2+ CD8+ T-cells including oligoconal expansions of MAIT cells are enriched in the airways in human tuberculosis EB Wong, MC Gold, EW Meermeier, BZ Xulu, S Khuzwayo, ZA Sullivan, ... Communications biology 2 (1), 203, 2019 | 67 | 2019 |
| MR1-independent activation of human mucosal-associated invariant T cells by mycobacteria S Suliman, M Murphy, M Musvosvi, A Gela, EW Meermeier, H Geldenhuys, ... The Journal of Immunology 203 (11), 2917-2927, 2019 | 65 | 2019 |
| A freshwater cyanophage whose genome indicates close relationships to photosynthetic marine cyanomyophages TW Dreher, N Brown, CS Bozarth, AD Schwartz, E Riscoe, C Thrash, ... Environmental microbiology 13 (7), 1858-1874, 2011 | 65 | 2011 |
| Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapy EW Meermeier, SJ Welsh, ME Sharik, MT Du, VM Garbitt, DL Riggs, ... Blood Cancer Discovery, 2021 | 60 | 2021 |
| Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy AM Stickles, LM Ting, JM Morrisey, Y Li, MW Mather, E Meermeier, ... The American journal of tropical medicine and hygiene 92 (6), 1195, 2015 | 53 | 2015 |
| T cell inactivation by poxviral B22 family proteins increases viral virulence D Alzhanova, E Hammarlund, J Reed, E Meermeier, S Rawlings, CA Ray, ... PLoS pathogens 10 (5), e1004123, 2014 | 53 | 2014 |
| Sontochin as a guide to the development of drugs against chloroquine-resistant malaria S Pou, RW Winter, A Nilsen, JX Kelly, Y Li, JS Doggett, EW Riscoe, ... Antimicrobial agents and chemotherapy 56 (7), 3475-3480, 2012 | 38 | 2012 |
| Engineering of isogenic cells deficient for MR1 with a CRISPR/Cas9 lentiviral system: Tools to study microbial antigen processing and presentation to human MR1-restricted T cells B Laugel, A Lloyd, EW Meermeier, MD Crowther, TR Connor, G Dolton, ... The Journal of Immunology 197 (3), 971-982, 2016 | 35 | 2016 |
| Monosomic Loss of MIR15A/MIR16-1 Is a Driver of Multiple Myeloma Proliferation and Disease Progression M Chesi, CK Stein, VM Garbitt, ME Sharik, YW Asmann, M Bergsagel, ... Blood Cancer Discovery, 2020 | 34 | 2020 |
| Identification of PIKfyve kinase as a target in multiple myeloma CB De Campos, YX Zhu, N Sepetov, S Romanov, LA Bruins, CX Shi, ... Haematologica 105 (6), 1641, 2019 | 32 | 2019 |
| Early clearance versus control: what is the meaning of a negative tuberculin skin test or interferon-gamma release assay following exposure to Mycobacterium tuberculosis? EW Meermeier, DM Lewinsohn F1000Research 7, 2018 | 22 | 2018 |
| Human lung-resident mucosal-associated invariant T cells are abundant, express antimicrobial proteins, and are cytokine responsive EW Meermeier, CL Zheng, JG Tran, S Soma, AH Worley, DI Weiss, ... Communications Biology 5 (1), 942, 2022 | 21 | 2022 |
| MR1-restricted MAIT cells from the human lung mucosal surface have distinct phenotypic, functional, and transcriptomic features that are preserved in HIV infection S Khuzwayo, M Mthembu, EW Meermeier, SM Prakadan, SW Kazer, ... Frontiers in immunology 12, 631410, 2021 | 21 | 2021 |
| The MAIT TCRβ chain contributes to discrimination of microbial ligand GA Narayanan, JE McLaren, EW Meermeier, K Ladell, GM Swarbrick, ... Immunology and cell biology 98 (9), 770-781, 2020 | 17 | 2020 |
| Alternative splicing of MR1 regulates antigen presentation to MAIT cells GA Narayanan, A Nellore, J Tran, AH Worley, EW Meermeier, ... Scientific Reports 10 (1), 15429, 2020 | 14 | 2020 |
| Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma SJ Welsh, BG Barwick, EW Meermeier, DL Riggs, CX Shi, YX Zhu, ... Blood cancer discovery 5 (1), 34-55, 2024 | 13 | 2024 |
David LewinsohnProfessor of Medicine, Oregon Health and Science UniversityBestätigte E-Mail-Adresse bei ohsu.edu
